Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0F6TM
|
||||
Former ID |
DNC012711
|
||||
Drug Name |
(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C11H9NO4
|
||||
Canonical SMILES |
C1=CC2=C(C=CC(=O)N2CC(=O)O)C=C1O
|
||||
InChI |
1S/C11H9NO4/c13-8-2-3-9-7(5-8)1-4-10(14)12(9)6-11(15)16/h1-5,13H,6H2,(H,15,16)
|
||||
InChIKey |
VDYFIKQEBBKQES-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Methylglyoxal degradation III | ||||
Acetone degradation I (to methylglyoxal) | |||||
KEGG Pathway | Pentose and glucuronate interconversions | ||||
Fructose and mannose metabolism | |||||
Galactose metabolism | |||||
Glycerolipid metabolism | |||||
Metabolic pathways | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
PathWhiz Pathway | Fructose and Mannose Degradation | ||||
Pyruvate Metabolism | |||||
Pterine Biosynthesis | |||||
Glycerolipid Metabolism | |||||
Galactose Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Polyol Pathway | |||||
Metabolism of steroid hormones and vitamin D | |||||
References | |||||
REF 1 | J Med Chem. 1986 Oct;29(10):2024-8.Synthesis and aldose reductase inhibitory activity of substituted 2-oxoquinoline-1-acetic acid derivatives. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.